SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-130078
Filing Date
2020-11-27
Accepted
2020-11-27 17:08:47
Documents
1
Period of Report
2020-11-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2037145d5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2037145d5_4seq1.xml 4 4589
  Complete submission text file 0001104659-20-130078.txt   6077
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Issuer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE, 12TH FLOOR NEW YORK NY 10017
Business Address
Bernstein Bruce (Reporting) CIK: 0001665472 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38045 | Film No.: 201355828